Introduction
============

Infantile diarrhoea is one of the major causes of morbidity and mortality in infancy in developing countries \[[@R1]\]. Among several factors, *Escherichia coli* (*E. coli*) infection is one of the major causes of diarrhoeal disease in the developing countries \[[@R2]\]. *E. coli* are Gram-negative opportunistic pathogens and belong to the genus *Enterobacteriaceae*. In general, *E. coli* is considered as a friendly organism present in the normal intestinal flora of humans and animals and can kill harmful bacteria by producing vitamins and other immunostimulants \[[@R3]\]. However, a number of *E. coli* strains acquire virulence factors and cause severe intestinal and urinary-tract infections \[[@R4]--[@R5]\]. *E. coli* serotypes are generally classified based on the somatic, flagella and capsular antigens \[[@R6]\]. Diarrhoea-causing *E. coli* strains are broadly classified in four categories: (a) Enteropathogenic *E. coli* infects through the production of heat-labile and heat-stable toxins; (b) enteroinvasive *E. coli* acts through the invasion of the host body; (c) enteropathogenic *E. coli* infects by adhering to the membrane of the host intestine; and (d) verotoxin *E. coli* infects by the production of verotoxin or shiga toxin \[[@R7]\]. Recently, Zhao et al. reported the structure of the repeating unit of the cell-wall antigenic lipopolysaccharide of *E. coli* O40 \[[@R8]\], which contains two D-galactosyl moieties with alpha and beta linkage, one beta-linked D-glucosamine and one beta-linked D-mannosyl moiety ([Fig. 1](#F1){ref-type="fig"}).

![Structure of the tetrasaccharide repeating unit of the cell-wall lipopolysaccharide of *Escherichia coli* O40.](Beilstein_J_Org_Chem-08-2053-g002){#F1}

Although several therapeutics have appeared in the past to control the diarrheal epidemics caused by *E. coli* infections, emergence of resistant strains is a serious concern in the development of therapeutics against this organism. Since, bacterial cell-wall lipopolysaccharides play important roles in the pathogenicity of the virulent strains, it would be pertinent to develop glycoconjugate therapeutics based on the cell-wall oligosaccharide haptens to reduce the number of infections \[[@R9]--[@R12]\]. In order to evaluate the therapeutic efficacy of the glycoconjugate derivatives it is essential to have a significant quantity of oligosaccharides, which is difficult to isolate from natural sources. Therefore, the development of a chemical synthetic strategy for the synthesis of the oligosaccharides and their close analogues can add momentum towards the preparation of glycoconjugate-based therapeutics. In this perspective, we report herein a concise chemical synthesis of the tetrasaccharide repeating unit of the cell-wall lipopolysaccharide of *E. coli* O40, using a convergent block synthetic strategy.

Results and Discussion
======================

The target tetrasaccharide **1** as its 2-aminoethyl glycoside was synthesized by a stereoselective glycosylation of a disaccharide acceptor **8** and a disaccharide thioglycoside donor **9** using a \[2 + 2\] block synthetic strategy. The disaccharide intermediates were synthesized from the suitably protected monosaccharide derivatives **2** \[[@R13]\], **3** \[[@R14]\], **4** \[[@R15]\] and **5** \[[@R16]\], which were prepared from the commercially available reducing sugars, by applying a series of functional group protection--deprotection methodologies ([Fig. 2](#F2){ref-type="fig"}). The synthetic strategy has a number of notable features, which include (a) stereoselective \[2 + 2\] block glycosylation; (b) application of general glycosylation reactions by using thioglycosides as glycosyl donors and a combination of *N*-iodosuccinimide (NIS) and perchloric acid supported over silica (HClO~4~--SiO~2~) \[[@R17]--[@R18]\] as glycosyl activator; (c) exploitation of the armed--disarmed glycosylation concept for the orthogonal activation of thioglycoside during the synthesis of disaccharide derivative **9** \[[@R19]\]; (d) use of aminoethyl linker as the anomeric protecting group; (e) removal of benzyl groups using a combination of triethylsilane and Pd(OH)~2~--C \[[@R20]\]; and (f) preparation of β-D-mannosidic moiety from the β-D-glucoside \[[@R13]\].

![Structure of the synthesized tetrasaccharide **1** and its synthetic precursors.](Beilstein_J_Org_Chem-08-2053-g003){#F2}

Benzylation of 2-azidoethyl 3-*O*-benzyl-4,6-*O*-benzylidene-β-D-mannopyranoside (**2**) \[[@R13]\] (prepared from D-glucose in nine steps) by using benzyl bromide and sodium hydroxide \[[@R21]\] followed by reductive ring opening of the 4,6-*O*-benzylidene acetal with triethylsilane and iodine \[[@R22]\] furnished compound **6** in 82% yield. Stereoselective glycosylation of compound **6** with thioglycoside derivative **3** in the presence of a combination of *N*-iodosuccinimide (NIS) and HClO~4~--SiO~2~ \[[@R17]\] gave disaccharide derivative **7** in a 77% yield. Formation of compound **7** was confirmed from its spectral analysis \[signals at δ 4.73 (d, *J* = 8.0 Hz, H-1~B~), 4.41 (br s, H-1~A~) in the ^1^H NMR and at δ 101.6 (C-1~A~), 100.7 (C-1~B~) in the ^13^C NMR spectra respectively\]. Saponification of compound **7** by using sodium methoxide followed by 3,4-*O*-isopropylidenation with 2,2-dimethoxypropane and *p*-toluenesulfonic acid \[[@R23]\] furnished disaccharide derivative **8** in 74% yield ([Scheme 1](#C1){ref-type="fig"}).

![Synthesis of disaccharide derivative **8**. Reagents and conditions: (a) benzyl bromide, NaOH, DMF, room temperature, 1 h; (b) Et~3~SiH, I~2~, CH~3~CN, 0 °C, 1 h, 82%; (c) NIS, HClO~4~--SiO~2~, MS 4Å, CH~2~Cl~2~, −25 °C, 1 h, 77%; (d) 0.1 M CH~3~ONa, CH~3~OH, room temperature, 3 h; (e) 2,2-dimethoxypropane, *p*-TsOH, DMF, room temperature, 5 h, 74%.](Beilstein_J_Org_Chem-08-2053-g004){#C1}

In a separate experiment, stereoselective glycosylation of thioglycoside derivative **4** with the thioglycoside acceptor **5** in the presence of a combination of NIS and HClO~4~--SiO~2~ \[[@R17]\] in dichloromethane--diethyl ether furnished disaccharide thioglycoside derivative **9** in a 74% yield together with a minor quantity of its other isomer (≈5%), which was separated by column chromatography. Formation of compound **9** was confirmed from its spectral analysis \[δ 5.51 (d, *J* = 3.5 Hz, H-1~D~), 5.37 (d, *J* = 10.5 Hz, H-1~C~) in the ^1^H NMR and δ 97.4 (C-1~D~), 83.0 (C-1~C~) in the ^13^C NMR spectra, respectively\]. During the synthesis of compound **9**, thioglycoside **4** acted as glycosyl donor and thioglycoside **5** acted as orthogonal glycosyl acceptor because of the difference in their reactivity following the "armed--disarmed glycosylation" concept \[[@R19],[@R24]\] ([Scheme 2](#C2){ref-type="fig"}).

![Synthesis of disaccharide derivative **9**. Reagents and conditions: (a) NIS, HClO~4~--SiO~2~, MS 4Å, CH~2~Cl~2~--Et~2~O, −25 °C, 1 h, 74%.](Beilstein_J_Org_Chem-08-2053-g005){#C2}

Iodonium ion promoted \[2 + 2\] stereoselective glycosylation of compound **8** and compound **9** in the presence of NIS and HClO~4~--SiO~2~ \[[@R17]\] furnished tetrasaccharide derivative **10** in 71% yield. Formation of compound **10** was confirmed by its spectral analysis \[signals at δ 101.6 (C-1~B~), 101.5 (PhC*H*), 100.8 (C-1~C~), 100.2 (C-1~A~), 97.3 (C-1~D~) in the ^13^C NMR spectrum\]. Compound **10** was subjected to a sequence of reactions involving (a) removal of *N*-phthalimido group by using hydrazine hydrate \[[@R25]\]; (b) *N*-acetylation by using acetic anhydride and pyridine; (c) removal of isopropylidene ketal and benzylidene acetal by acid hydrolysis; and finally (d) removal of benzyl ethers by using triethylsilane and 20% Pd(OH)~2~--C \[[@R20]\] to furnish target compound **1**, which was purified through a Sephadex^®^ LH-20 column to give pure compound **1** in 60% overall yield. Spectral data of compound **1** confirmed its formation \[signals at δ 5.31 (d, *J* = 8.5 Hz, H-1~C~), 5.15 (d, *J* = 3.5 Hz, H-1~D~), 4.63 (br s, H-1~A~), 4.34 (d, *J* = 8.5 Hz, H-1~B~) in the ^1^H NMR and at δ 100.7 (C-1~B~), 100.6 (C-1~B~), 99.6 (2 C, C-1~A~, C-1~C~) in the ^13^C NMR\] ([Scheme 3](#C3){ref-type="fig"}).

![Synthesis of target tetrasaccharide **1**. Reagents and conditions: (a) NIS, HClO~4~--SiO~2~, CH~2~Cl~2~, −15 °C, 1 h, 71%; (b) NH~2~NH~2~·H~2~O, EtOH, 90 °C, 5 h; (c) acetic anhydride, pyridine, room temperature, 2 h; (d) 80% aq AcOH, 80 °C, 1.5 h; (e) triethylsilane, 20% Pd(OH)~2~--C, CH~3~OH, 6 h, room temperature, overall 60%.](Beilstein_J_Org_Chem-08-2053-g006){#C3}

Conclusion
==========

In summary, synthesis of a tetrasaccharide repeating unit corresponding to the cell-wall lipopolysaccharide of *E. coli* O40 was achieved by using a convergent \[2 + 2\] block synthetic strategy. The yields are excellent in all reactions. A general reaction condition was used in all glycosylation reactions. All intermediates and final compounds were characterized by their spectral analysis. The armed--disarmed glycosylation concept was applied for the synthesis of disaccharide derivative **9**. A 2-Aminoethyl linker was used as the anomeric protecting group.

Experimental
============

**General methods:** All reactions were monitored by thin-layer chromatography over silica-gel-coated TLC plates. The spots on TLC were visualized by warming ceric sulfate (2% Ce(SO~4~)~2~ in 2 N H~2~SO~4~)-sprayed plates on a hot plate. Silica gel 230--400 mesh was used for column chromatography. ^1^H and ^13^C NMR spectra were recorded on Brucker Avance 500 MHz by using CDCl~3~ as solvent and TMS as internal reference, unless stated otherwise. Chemical shift values are expressed in δ ppm. MALDI-MS were recorded on a Bruker Daltronics mass spectrometer. Commercially available grades of organic solvents of adequate purity were used in all reactions. HClO~4~--SiO~2~ was prepared following the method reported in the literature \[[@R18]\].

**2-Azidoethyl 2,3,6-tri-** ***O*** **-benzyl-β-D-mannopyranoside (6)**: To a solution of compound **2** (2.0 g, 4.68 mmol) in dry DMF (10 mL) were added benzyl bromide (1.2 mL, 10.09 mmol) and powdered NaOH (750.0 mg, 18.75 mmol) and the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with water (100 mL) and extracted with CH~2~Cl~2~ (100 mL). The organic layer was washed with H~2~O, dried (Na~2~SO~4~) and concentrated. The crude product was passed through a short pad of SiO~2~ by using hexane--EtOAc (5:1) as eluant to give the *O*-benzylated product (2.2 g, 91%). A solution of the *O*-benzylated product (2.2 g, 4.25 mmol) in dry CH~3~CN (20 mL) was cooled to 0 °C. To the cooled reaction mixture were added Et~3~SiH (1.4 mL, 8.76 mmol) and I~2~ (250.0 mg, 0.98 mmol), and the reaction mixture was stirred at the same temperature for 1 h. The reaction mixture was diluted with CH~2~Cl~2~ (100 mL) and the organic layer was successively washed with saturated NaHCO~3~ and H~2~O, and then dried (Na~2~SO~4~) and concentrated. The crude product was purified over SiO~2~ by using hexane--EtOAc (4:1) as eluant to give pure compound **6** (1.7 g, overall 82%). White solid; mp 89--90 °C; \[α\]~D~ ^25^ −97 (*c* 1.0, CHCl~3~); IR (KBr): 3293, 2845, 2110, 1497, 1454, 1365, 1310, 1119, 1065, 779, 659, 599 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.43--7.23 (m, 15H, Ar-H), 4.98 (d, *J* = 12.5 Hz, 1H, PhC*H* ~2~), 4.75 (d, *J* = 12.5 Hz, 1H, PhC*H* ~2~), 4.61, 4.58 (2 d, *J* = 12.0 Hz, 2H, PhC*H* ~2~), 4.48 (br s, 1H, H-1), 4.45 (d, *J* = 12.0 Hz, 1H, PhC*H* ~2~), 4.32 (d, *J* = 12.0 Hz, 1H, PhC*H* ~2~), 4.15--4.11 (m, 1H,-OC*H* ~2~-), 3.96 (br s, 1H, H-2), 3.94 (t, *J* = 9.5 Hz each, 1H, H-4), 3.85 (dd, *J* = 10.5, 3.5 Hz, 1H, H-6~a~), 3.75 (dd, *J* = 10.5, 6.5 Hz, 1H, H-6~b~), 3.66--3.62 (m, 1H, OC*H* ~2~-), 3.58--3.53 (m, 1H, C*H* ~2~N~3~), 3.46--3.42 (m, 1H, H-5), 3.34--3.30 (m, 1H, C*H* ~2~N~3~), 3.29 (dd, *J* = 10.0, 3.5 Hz, 1H, H-3); ^13^C NMR (125 MHz, CDCl~3~) δ 138.6--127.4 (Ar-C), 101.8 (C-1), 81.3 (C-3), 75.4 (C-5), 74.4 (Ph*C*H~2~), 73.7 (Ph*C*H~2~), 73.5 (C-5), 71.1 (Ph*C*H~2~), 70.7 (C-6), 68.6 (O*C*H~2~), 68.0 (C-2), 50.9 (*C*H~2~N~3~); ESI-MS: 542.2 \[M + Na\]^+^; Anal. calcd for C~29~H~33~N~3~O~6~: C, 67.04; H, 6.40; found: C, 66.90; H, 6.58.

**2-Azidoethyl** ***O*** **-(2,3,4-tri-** ***O*** **-acetyl-6-** ***O*** **-benzyl-β-D-galactopyranosyl)-(1→4)-2,3,6-tri-** ***O*** **-benzyl-β-D-mannopyranoside (7)**: To a solution of compound **3** (1.4 g, 3.18 mmol) and compound **6** (1.5 g, 2.88 mmol) in anhydrous CH~2~Cl~2~ (10 mL) was added MS 4Å (2.0 g), and the reaction mixture was stirred at room temperature for 30 min under argon. The reaction mixture was cooled to −25 °C, and *N*-iodosuccinimide (NIS; 0.8 g, 3.55 mmol) and HClO~4~--SiO~2~ (25.0 mg) were added to it. After being stirred at same temperature for 1 h the reaction mixture was filtered through a Celite^®^ bed and washed with CH~2~Cl~2~ (100 mL). The organic layer was successively washed with 5% Na~2~S~2~O~3~, saturated NaHCO~3~ and water, and then dried (Na~2~SO~4~) and concentrated under reduced pressure to give the crude product. The crude product was purified over SiO~2~ by using hexane--EtOAc (7:1) as eluant to give pure compound **7** (2.0 g, 77%). Yellow oil; \[α\]~D~ ^25^ −13 (*c* 1.0, CHCl~3~); IR (neat): 3087, 2956, 2153, 1605, 1487, 1345, 1254, 1183, 1142, 1045, 999, 774, 734, 647, 542 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.35--7.16 (m, 20H, Ar-H), 5.33 (d, *J* = 3.0 Hz, 1H, H-4~B~), 5.06 (t, *J* = 8.0 Hz each, 1H, H-2~B~), 4.87 (d, *J* = 12.0 Hz, 1H, PhC*H* ~2~), 4.84 (dd, *J* = 10.5, 3.5 Hz, 1H, H-3~B~), 4.73 (d, *J* = 8.0 Hz, 1H, H-1~B~), 4.72--4.71 (2 d, *J* = 12.0 Hz each, 2H, PhC*H* ~2~), 4.59 (d, *J* = 12.0 Hz, 1H, PhC*H* ~2~), 4.47, 4.45 (2 d, *J* = 12.0 Hz each, 2H, PhC*H* ~2~), 4.41 (br s, 1H, H-1~A~), 4.39 (d, *J* = 12.0 Hz, 1H, PhC*H* ~2~), 4.19 (d, *J* = 12.0 Hz, 1H, PhC*H* ~2~), 4.14 (t, *J* = 9.0 Hz each, 1H, H-4~A~), 4.10--4.05 (m, 1H, OC*H* ~2~), 3.92 (d, *J* = 3.0 Hz, 1H, H-2~A~), 3.76--3.70 (m, 2H, H-6~abA~), 3.65--3.60 (m, 1H, OC*H* ~2~), 3.54--3.49 (m, 2H, H-5~B~, C*H* ~2~N~3~), 3.47 (dd, *J* = 10.0, 3.0 Hz, 1H, H-3~A~), 3.42--3.38 (m, 1H, H-5~A~), 3.32--3.22 (m, 3H, H-6~abB~, C*H* ~2~N~3~), 1.99, 1.95, 1.90 (3 s, 9H, 3 COC*H* ~3~); ^13^C NMR (125 MHz, CDCl~3~) δ 169.9, 169.8, 169.4 (3 *C*OCH~3~), 138.5--126.8 (Ar-C), 101.6 (C-1~A~), 100.7 (C-1~B~), 80.6 (C-5~B~), 75.7 (C-5~A~), 74.7 (C-2~A~), 74.3 (2 C, C-4~A~, Ph*C*H~2~), 73.7 (Ph*C*H~2~), 73.3 (Ph*C*H~2~), 71.7 (C-5~B~), 71.5 (Ph*C*H~2~), 71.3 (C-3~B~), 70.0 (C-2~B~), 68.6 (C-6~A~), 68.5 (O*C*H~2~), 67.4 (C-4~B~), 66.9 (C-6~B~), 50.8 (*C*H~2~N~3~), 20.7, 20.6, 20.5 (CO*C*H~3~); MALDI-MS: 920.3 \[M + Na\]^+^; Anal. calcd for C~48~H~55~N~3~O~14~: C, 64.20; H, 6.17; found: C, 64.06; H, 6.35.

**2-Azidoethyl** ***O*** **-(6-** ***O*** **-benzyl-3,4-** ***O*** **-isopropylidene-β-D-galactopyranosyl)-(1→4)-2,3,6-tri-** ***O*** **-benzyl-β-D-mannopyranoside (8)**: A solution of compound **7** (1.8 g, 2.0 mmol) in 0.1 M CH~3~ONa (25 mL) was stirred at room temperature for 2 h. The reaction mixture was neutralized with Dowex 50W X8 (H^+^) resin, filtered and concentrated. To a solution of the de-*O*-acetylated product in dry DMF (10 mL) was added 2,2-dimethoxypropane (0.7 mL, 5.69 mmol) followed by *p*-TsOH (0.2 g) and the reaction mixture was stirred at room temperature for 5 h. The reaction was quenched with Et~3~N (1 mL), the solvents were removed under reduced pressure, and the crude reaction mixture was diluted with CH~2~Cl~2~ (100 mL). The organic layer was washed with saturated NaHCO~3~, dried (Na~2~SO~4~) and concentrated to give the crude product, which was purified over SiO~2~ by using hexane--EtOAc (2:1) as eluant to give pure compound **8** (1.2 g, 74%). Yellow oil; \[α\]~D~ ^25^ −21 (*c* 1.0, CHCl~3~); IR (neat): 3418, 3030, 2926, 2198, 1743, 1711, 1646, 1390, 1253, 1099, 1053, 864, 754, 667, 531 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.30--7.14 (m, 20H, Ar-H), 4.84 (d, *J* = 12.5 Hz, 1H, PhC*H* ~2~), 4.63--4.40 (m, 6H, PhC*H* ~2~), 4.38 (d, *J* = 8.0 Hz, 1H, H-1~B~), 4.33 (br s, 1H, H-1~A~), 4.30 (d, *J* = 12.5 Hz, 1H, PhC*H* ~2~), 4.22 (t, *J* = 9.5 Hz each, 1H, H-4~A~), 4.02--3.98 (m, 2H, H-2~A~, OC*H* ~2~), 3.91 (dd, *J* = 10.0, 3.5 Hz, H-3~B~), 3.83 (dd, *J* = 12.0, 5.5 Hz, 1H, H-6~aB~), 3.81 (d, *J* = 2.0 Hz, 1H, H-4~B~), 3.76 (dd, *J* = 12.0, 2.0, Hz, 1H, H-6~bB~), 3.71 (br s, 1H, H-5~B~), 3.70--3.68 (m, 1H, OC*H* ~2~), 3.62--3.58 (m, 1H, H-6~aA~), 3.56--3.51 (m, 1H, C*H* ~2~N~3~), 3.49 (dd, *J* = 8.0 Hz each, 1H, H-2~B~), 3.47--3.43 (m, 1H, H-6~bA~), 3.42--3.37 (m, 2H, H-3~A~, H-5~A~), 3.25--3.19 (m, 1H, C*H* ~2~N~3~), 1.42, 1.25 (2 s, 6H, 2 C(C*H* ~3~)~3~); ^13^C NMR (125 MHz, CDCl~3~) δ 138.7--127.3 (Ar-C), 109.8 (*C*(CH~3~)~2~), 102.5 (C-1~B~), 101.9 (C-1~A~), 80.6 (C-2~B~), 78.9 (C-3~B~), 75.2 (C-5~A~), 74.3 (Ph*C*H~2~), 74.2 (C-3~A~), 74.0 (C-4~B~), 73.8 (C-2~A~), 73.5 (Ph*C*H~2~), 73.4 (2C, C-4~A~, Ph*C*H~2~), 72.4 (C-5~B~), 71.3 (Ph*C*H~2~), 69.4 (O*C*H~2~), 69.3 (C-6~B~), 68.5 (C-6~A~), 50.8 (*C*H~2~N~3~), 28.2, 26.4 (C(*C*H~3~)~2~); MALDI-MS: 834.3 \[M + Na\]^+^; Anal. calcd for C~45~H~53~N~3~O~11~: C, 66.57; H, 6.58; found: C, 66.42; H, 6.75.

**Ethyl** ***O*** **-(2,3,4,6-tetra-** ***O*** **-benzyl-α-D-galactopyranosyl)-(1→3)-4,6-** ***O*** **-benzylidene-2-deoxy-2-** ***N*** **-phthalimido-1-thio-β-D-glucopyranoside (9):** To a solution of compound **4** (1.4 g, 2.39 mmol) and compound **5** (1.0 g, 2.26 mmol) in anhydrous CH~2~Cl~2~--Et~2~O (10 mL; 1:1 v/v) was added MS 4Å (2.0 g), and reaction mixture was stirred at room temperature for 30 min under argon. The reaction mixture was cooled to −25 °C and NIS (550.0 mg, 2.44 mmol) and HClO~4~--SiO~2~ (15.0 mg) were added. After being stirred at same temperature for 1 h the reaction mixture was filtered through a Celite^®^ bed and washed with CH~2~Cl~2~ (100 mL). The organic layer was successively washed with 5% Na~2~S~2~O~3~, saturated NaHCO~3~ and water, and then dried (Na~2~SO~4~) and concentrated under reduced pressure to give the crude product. The crude product was purified over SiO~2~ by using hexane--EtOAc (7:1) as eluant to give pure compound **9** (1.6 g, 74%). White solid; mp 67--68 °C; \[α\]~D~ ^25^ +39 (*c* 1.0, CHCl~3~); IR (KBr): 3417, 3063, 2870, 1774, 1715, 1610, 1495, 1485, 1385, 1216, 1099, 1023, 914, 753, 719 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.76--6.91 (m, 29H, Ar-H), 5.51 (d, *J* = 3.5 Hz, 1H, H-1~D~), 5.37 (d, *J* = 10.5 Hz, 1H, H-1~C~), 5.32 (s, 1H, PhC*H*), 4.84 (t, *J* = 9.5 Hz each, 1H, H-3~C~), 4.77--4.58 (3 d, *J* = 12.0 Hz each, 3H, PhC*H* ~2~), 4.46 (t, *J* = 9.5 Hz each, 1H, H-2~C~), 4.44 (d, *J* = 11.5 Hz, 1H, PhC*H* ~2~), 4.34 (d, *J* = 11.5 Hz, 1H, PhC*H* ~2~), 4.29 (t, *J* = 9.5 Hz each, 1H, H-4~C~), 4.19 (d, *J* = 11.5 Hz, 1H, PhC*H* ~2~), 3.86 (br s, 2H, PhC*H* ~2~), 3.85 (br s, 1H, H-4~D~), 3.81 (dd, *J* = 10.5, 3.0 Hz, 1H, H-2~D~), 3.72--3.67 (m, 3H, H-3~D~, H-5~C~, H-6~aD~), 3.58 (br s, 1H, H-5~D~), 3.33--3.31 (m, 1H, H-6~bD~), 3.23--3.19 (m, 1H, H-6~aC~), 2.80--2.77 (m, 1H, H-6~bC~), 2.67--2.56 (m, 2H, SC*H* ~2~CH~3~), 1.12 (t, *J* = 7.5 Hz each, 3H, SCH~2~C*H* ~3~); ^13^C NMR (125 MHz, CDCl~3~) δ 168.1, 167.9 (Phth*C*O), 138.9--123.1 (Ar-C), 101.7 (Ph*C*H), 97.4 (C-1~D~), 83.0 (C-1~C~), 81.7 (C-4~D~), 78.1 (C-3~D~), 75.4 (C-2~D~), 74.8 (C-5~D~), 74.7 (Ph*C*H~2~), 73.3 (2 C, C-3~C~, Ph*C*H~2~), 72.8 (Ph*C*H~2~), 71.8 (Ph*C*H~2~), 70.1 (C-5~C~), 69.4 (C-4~C~), 68.8 (C-6~D~), 67.7 (C-6~C~), 54.2 (C-2~C~), 24.0 (S*C*H~2~CH~3~), 14.9 (SCH~2~ *C*H~3~); MALDI-MS: 986.3 \[M + Na\]^+^; Anal. calcd for C~57~H~57~NO~11~S: C, 71.01; H, 5.96; found: C, 70.88; H, 6.13.

**2-Azidoethyl** ***O*** **-(2,3,4,6-tetra-** ***O*** **-benzyl-α-D-galactopyranosyl)-(1→3)-** ***O*** **-(4,6-** ***O*** **-benzylidene-2-deoxy-2-** ***N*** **-phthalimido-β-D-glucopyranosyl)-(1→2)-** ***O*** **-(6-** ***O*** **-benzyl-3,4-** ***O*** **-isopropylidene-β-D-galactopyranosyl)-(1→4)-2,3,6-tri-** ***O*** **-benzyl-β-D-mannopyranoside (10):** To a solution of compound **8** (1.0 g, 1.23 mmol) and compound **9** (1.3 g, 1.35 mmol) in anhydrous CH~2~Cl~2~ (10 mL) was added MS 4Å (2.0 g), and reaction mixture was stirred at room temperature for 30 min under argon. The reaction mixture was cooled to −25 °C and NIS (350.0 mg, 1.55 mmol) and HClO~4~--SiO~2~ (10.0 mg) were added to it. After being stirred at same temperature for 1 h the reaction mixture was filtered through a Celite^®^ bed and washed with CH~2~Cl~2~ (100 mL). The organic layer was successively washed with 5% Na~2~S~2~O~3~, saturated NaHCO~3~ and water, and then dried (Na~2~SO~4~) and concentrated under reduced pressure to give the crude product. The crude product was purified over SiO~2~ by using hexane--EtOAc (7:1) as eluant to give pure compound **10** (1.5 g, 71%). White solid; mp 65--66 °C; \[α\]~D~ ^25^ +34 (*c* 1.0, CHCl~3~); IR (KBr): 3423, 3063, 3030, 2871, 2105, 1776, 1744, 1715, 1497, 1454, 1389, 1239, 1102, 1060, 874, 737, 721, 697, 600, 530 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 7.76--6.96 (m, 49H, Ar-H), 5.52 (d, *J* = 3.5 Hz, 1H, H-1~D~), 5.42 (d, *J* = 8.0 Hz, 1H, H-1~C~), 5.25 (s, 1H, PhC*H*), 4.86--4.45 (m, 13H, PhC*H* ~2~), 4.41 (d, *J* = 9.5 Hz, 1H, H-1~B~), 4.37 (t, *J* = 8.0 Hz, 1H, H-2~C~), 4.29 (d, *J* = 11.5 Hz, 1H, PhC*H* ~2~), 4.24--4.20 (m, 4H, H-1~A~, H-3~C~, H-4~A~, OC*H* ~2~), 4.13--4.08 (m, 2H, H-2~A~, OC*H* ~2~), 3.91 (br s, 2H, PhC*H* ~2~), 3.89--3.85 (m, 3H, H-2~D~, H-3~B~, H-3~D~), 3.84--3.75 (m, 3H, H-2~B~, H-4~C~, H-4~D~), 3.70 (t, *J* = 10.5 Hz each, 1H, H-6~aB~), 3.64--3.60 (m, 4H, H-4~B~, H-5~B~, H-5~D~, H-6~bB~), 3.58--3.43 (m, 5H, H-3~A~, H-6~aA~, H-6~aC~, H-6~abD~), 3.42--3.36 (m, 4H, H-5~A~, H-6~bA~, H-6~bC~, C*H* ~2~N~3~), 3.34--3.26 (m, 2H, H-5~C~, C*H* ~2~N~3~), 1.27, 1.25 (2 s, 6H, 2 C*H* ~3~); ^13^C NMR (125 MHz, CDCl~3~) δ 138.6--126.3 (Ar-C), 109.5 (*C*(CH~3~)~2~), 101.6 (C-1~B~), 101.5 (PhC*H*), 100.8 (C-1~C~), 100.2 (C-1~A~), 97.3 (C-1~D~), 82.9 (C-4~C~), 82.7 (C-5~A~), 80.1 (C-5c), 78.7 (C-3~A~), 78.1 (C-4~D~), 76.2 (C-2~D~), 75.5 (C-2~B~), 74.9 (C-3~B~), 74.8 (C-5~D~), 74.7 (Ph*C*H~2~), 74.6 (C-3~D~), 73.9 (Ph*C*H~2~) 73.5 (C-3~C~), 73.4 (2 C, 2 Ph*C*H~2~), 73.2 (Ph*C*H~2~), 72.8 (Ph*C*H~2~), 72.6 (C-2~A~), 72.0 (Ph*C*H~2~), 71.7 (2 C, C-4~B~, Ph*C*H~2~), 69.3 (C-4~A~), 68.9 (C-6~C~), 68.8 (O*C*H~2~), 68.7 (C-6~A~), 68.4 (O*C*H~2~), 67.7 (2 C, C-6~B~, C-6~D~), 65.4 (C-5~B~), 56.0 (C-2~C~), 50.8 (*C*H~2~N~3~), 27.6, 25.7 (C(*C*H~3~)~2~); MALDI-MS: 1735.7 \[M + Na\]^+^; Anal. calcd for C~100~H~104~N~4~O~22~: C, 70.08; H, 6.12; found: C, 69.94; H, 6.30.

**2-Aminoethyl (α-D-galactopyranosyl)-(1→3)-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1→2)-(β-D-galactopyranosyl)-(1→4)-β-D-mannopyranoside (1):** To a solution of compound **10** (500.0 mg, 0.29 mmol) in EtOH (5 mL) was added NH~2~NH~2~·H~2~O (0.1 mL) and the reaction mixture was stirred at 90 °C for 5 h. The solvents were removed under reduced pressure, and a solution of the crude product in acetic anhydride--pyridine (2 mL, 1:1 v/v) was kept at room temperature for 2 h and then concentrated. A solution of the crude product in 80% aq AcOH (10 mL) was stirred at 80 °C for 1.5 h and then concentrated. To a solution of the crude product in CH~3~OH (5 mL) were added Et~3~SiH (1.5 mL, 9.39 mmol) and 20% Pd(OH)~2~--C (100.0 mg) and the reaction mixture was stirred at room temperature for 6 h. The reaction mixture was filtered through a Celite^®^ bed and washed with CH~3~OH--H~2~O (2:1). The solvents were removed under reduced pressure and the product was passed through a Sephadex^®^ LH-20 column by using CH~3~OH--H~2~O (3:1) as eluant to furnish pure compound **1** (135.0 mg, 60%). Glass; \[α\]~D~ ^25^ +29 (*c* 1.0, H~2~O); IR (KBr): 3436, 2948, 1619, 1369, 1162, 669 cm^−1^; ^1^H NMR (500 MHz, D~2~O) δ 5.31 (d, *J* = 8.5 Hz, 1H, H-1~C~), 5.15 (d, *J* = 3.5 Hz, 1H, H-1~D~), 4.63 (br s, 1H, H-1~A~), 4.48 (t, *J* = 10.5 Hz each, 1H, H-3~C~), 4.34 (d, *J* = 8.5 Hz, 1H, H-1~B~), 4.09 (t, *J* = 10.0 Hz each, 1H, H-2~C~), 4.05--3.92 (m, 4H, H-2~A~, H-4~D~, H-5~D~, OC*H* ~2a~), 3.90--3.80 (m, 4H, H-2~B~, H-3~A~, H-6~aB~, OC*H* ~2b~), 3.78--3.57 (m, 11H, H-3~D~, H-4~B~, H-4~C~, H-6~abA~, H-6~bB~, H-6~abC~, H-6~abD~), 3.55--3.47 (m, 2H, H-2~D~, H-3~B~), 3.45--3.40 (m, 2H, H-5~A~, H-5~B~), 3.35--3.33 (m, 1H, H-5~C~), 3.20--3.15 (m, 2H, C*H* ~2~NH~2~), 2.06 (s, 3H, COC*H* ~3~); ^13^C NMR (125 MHz, D~2~O) δ 171.5 (*C*OCH~3~), 100.7 (C-1~B~), 100.6 (C-1~B~), 99.6 (2C, C-1~A~, C-1~C~), 81.7 (C-3~B~), 79.0 (C-3~C~), 78.5 (C-4~D~), 77.0 (C-3~D~), 75.5 (C-4~A~), 75.1 (C-4~B~), 73.5 (C-2~D~), 73.3 (C-5~A~), 71.3 (C-2~A~), 70.7 (C-4~C~), 70.6 (C-3~A~), 69.8 (2 C, C-5~C~, C-5~D~), 68.3 (2C, C-2~B~, C-5~B~), 65.5 (O*C*H~2~), 60.6 (C-6~B~), 60.5 (C-6~C~), 60.2 (C-6~A~), 59.2 (C-6~D~), 55.7 (C-2~C~), 39.5 (*C*H~2~NH~2~), 23.1 (CO*C*H~3~); MALDI-MS: 799.2 \[M + Na\]^+^; Anal. calcd for C~28~H~48~N~4~O~21~: C, 43.30; H, 6.23; found: C, 43.14; H, 6.45.
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###### 

1D and 2D NMR spectra of compounds **1** and **6--10**.
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